Scalp Psoriasis Clinical Trial
Official title:
A Randomized, Double-Blind Study Comparing TOLMAR Calcipotriene and Betamethasone Suspension to Reference Listed Drug in the Treatment of Scalp Psoriasis
This study will be conducted to evaluate the therapeutic bioequivalence of a TEST formulation of calcipotriene hydrate and betamethasone dipropionate topical suspension 0.005%/0.064% to the RLD.
Randomized, Double-Blind, Placebo-Controlled, Multiple-Site, Parallel Design, Bioequivalence with Clinical Endpoints. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00400725 -
Maintenance Effect of Clobex Shampoo on Participants With Moderate to Severe Scalp Psoriasis
|
Phase 3 | |
| Completed |
NCT01195831 -
Efficacy and Safety of Xamiol® Gel Compared to Calcipotriol Scalp Solution in Patients With Scalp Psoriasis
|
Phase 3 | |
| Completed |
NCT03880357 -
To Evaluate the Therapeutic Equivalence and Safety in Treatment of Scalp Psoriasis
|
Phase 1 | |
| Completed |
NCT03331523 -
To Study Generic Calcipotriene and Betamethasone Dipropionate Topical Suspension, 0.005%/0.064%, in the Treatment of Scalp Psoriasis
|
Phase 3 | |
| Completed |
NCT04801433 -
Evaluate the Efficacy and Safety of Boroda Supramolecular Active Zinc in the Treatment of Scalp Psoriasis
|
N/A | |
| Completed |
NCT01120223 -
Safety and Efficacy of LEO 80185 Gel in Adolescent Subjects (Aged 12 to 17) With Scalp Psoriasis
|
Phase 2 | |
| Completed |
NCT03897088 -
Efficacy and Safety of Tildrakizumab in the Treatment of Scalp Psoriasis
|
Phase 3 | |
| Completed |
NCT02932462 -
Study to Evaluate Efficacy and Safety of the Topical Product in Patients With Mild to Severe Scalp Psoriasis
|
Phase 3 | |
| Completed |
NCT02933866 -
Phase III Clinical Study in Patients With Mild to Severe Scalp Psoriasis
|
Phase 3 | |
| Completed |
NCT05872256 -
A Demonstration of the Hair and Scalp Benefits of Duobrii in Scalp Psoriasis
|
Phase 4 | |
| Active, not recruiting |
NCT05272150 -
Study of Guselkumab in Skin of Color Participants With Moderate-to-severe Plaque and/or Scalp Psoriasis
|
Phase 3 | |
| Completed |
NCT02933502 -
Safety Study in Patients With Scalp Psoriasis Suppression Following Maximal Use Treatment With Topical Product
|
Phase 2 | |
| Completed |
NCT01052467 -
Topical Treatment of Scalp Psoriasis With the Fixed Combination of Calcipotriol and Betamethason (Xamiol® Gel)
|
N/A | |
| Completed |
NCT04243486 -
A Study of the Safety and Efficacy of UHE-105 Shampoo in Subjects With Scalp Psoriasis
|
Phase 2 | |
| Recruiting |
NCT02749656 -
Efficacy and Safety of 0.25% Desoximetasone Cream (Topoxy®) in the Treatment of Scalp Psoriasis
|
Phase 3 | |
| Completed |
NCT02078297 -
IL-17 Role in Variants of Psoriasis
|
N/A | |
| Completed |
NCT00438399 -
Subject Preference for Scalp Psoriasis Treatment
|
Phase 3 | |
| Completed |
NCT05028582 -
Topical Roflumilast to Treat Scalp and Body Psoriasis (ARRECTOR)
|
Phase 3 | |
| Completed |
NCT01914627 -
Parallel Group Trial to Evaluate the Efficacy and Safety of Loion® Compared to 10% Salicylic Acid in Patients With Chronic Psoriasis Capitis
|
Phase 2 | |
| Not yet recruiting |
NCT01558310 -
A Study to Evaluate the Effectiveness of STELARA ™ (USTEKINUMAB) in the Treatment of Scalp Psoriasis
|
Phase 4 |